| Attributs | Valeurs |
|---|
| type
| |
| Is Part Of
| |
| Subject
| |
| Title
| - An Individualized Blood Coagulation Model to Predict INR Therapeutic Range During Warfarin Treatment
|
| Date
| |
| has manifestation of work
| |
| related by
| |
| Author
| |
| Editor
| |
| Abstract
| - Deep venous thrombosis (DVT) is characterized by formation of blood clot within a deep vein. The resulting thrombus can partially or completely block blood circulation. It can also detach and migrate with the flow resulting in pulmonary embolism. Anticoagulant drugs such as warfarin are usually prescribed to prevent recurrent thrombosis. The action of warfarin is monitored using a blood test for the International Normalized Ratio (INR) which is based on prothrombin time measurement. A high INR indicates a predisposition of the patient to bleeding, while a low INR shows that the warfarin dose is insufficient to prevent thromboembolic events. The therapeutic target of INR varies from case to case depending on clinical indications. It tends to be in the range 2.0 - 3.0 in most conditions. In this work we develop a model describing blood clotting during warfarin treatment. The action of warfarin is introduced by a Pharmacokinetics-Pharmacodynamics (PK-PD) sub-model. It describes the inhibition of synthesis of the vitamin K dependent factors by warfarin in the liver. We generate a population of patients with individual characteristics and assess their response to warfarin treatment by comparing the simulated INR and the corresponding developed clot height. Using this approach, we determine the underlying causes behind thrombosis and bleeding persistence even for an INR in the normal range. Thus, we suggest a novel methodology to predict the targeted INR depending on individual patient characteristics.
|
| article type
| |
| publisher identifier
| |
| Date Copyrighted
| |
| Rights
| |
| Rights Holder
| |
| is part of this journal
| |
| is primary topic
of | |
